## STZ: Constellation Brands, Inc. - XLP: Consumer Defensive

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 4.7% in mid entry zone (3.0-6.0%), top quartile (82nd pct) cross-sectional ranking. Short-term MRS_5 (2.2%) confirms momentum alignment. Strong momentum (+2.2% 5-day acceleration). Outperforming sector by 3.4%. Caution: overbought RSI (71).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($141.04)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Constellation Brands to Report Third Quarter 2026 Financial Results on January 7, 2026 After Market Close and Host Conference Call on January 8, 2026 at 10:30 AM ET**
- Source: Sahm | 20251211T190849 | Neutral | Relevance: 100%
- Constellation Brands, Inc. announced it will report its third-quarter financial results for the period ended November 30, 2025, on January 7, 2026, after market close. The company will host a live conference call for analysts on January 8, 2026, at 10:30 AM ET to discuss the results, operating performance, and future outlook. The earnings release and supporting materials will be available on the company's investor relations website.

**2. Tilray Brands (TLRY) Stock Jumps on Trump Marijuana Rescheduling Report: Latest News, Forecasts, and Analyst Views (Dec. 12, 2025)**
- Source: ts2.tech | 20251212T120927 | Neutral | Relevance: 65%
- Tilray Brands (TLRY) stock surged following reports that President Trump is expected to push for rescheduling marijuana to a Schedule III substance, which could significantly alter the regulatory landscape for the cannabis industry. While this news has driven a rally among cannabis stocks, the long-term implications and final implementation details remain uncertain. Analysts maintain mixed views on Tilray, balancing potential policy tailwinds with execution challenges and recent corporate actions like its reverse stock split.

**3. AYAL Capital Advisors Ltd Purchases 160,002 Shares of NETGEAR, Inc. $NTGR**
- Source: MarketBeat | 20251213T120904 | Neutral | Relevance: 65%
- AYAL Capital Advisors Ltd significantly increased its stake in NETGEAR, Inc. (NASDAQ:NTGR) by 177.8% in Q2, acquiring an additional 160,002 shares to bring its total holding to 250,002 shares, valued at approximately $7.27 million. This investment accounts for about 1.7% of AYAL's portfolio. Analysts generally have a "Moderate Buy" rating for NETGEAR with an average price target of $37.33, despite recent insider selling and mixed individual ratings.

**4. Tilray Brands (TLRY) Soars After Reverse Stock Split and Cannabis Bill Hopes: Stock Forecast, Price Targets and 2026 Outlook**
- Source: ts2.tech | 20251210T220927 | Somewhat-Bullish | Relevance: 65%
- Tilray Brands (TLRY) recently experienced a significant stock rebound following a 1-for-10 reverse stock split and renewed optimism around cannabis legislation in the U.S. While the reverse split addressed Nasdaq compliance, the company continues to face challenges including modest revenue growth, substantial impairment charges, and negative cash flow. Strategic diversification into beverages and hemp-derived THC products aims to mitigate risks, but new U.S. crackdowns on hemp pose a significant threat to its growth in the psychoactive market.

**5. Diageo plc (NYSE:DEO) Given Consensus Rating of "Reduce" by Brokerages**
- Source: MarketBeat | 20251211T021130 | Neutral | Relevance: 64%
- Nine brokerages have issued a consensus "Reduce" rating for Diageo plc (NYSE:DEO), with analysts setting an average one-year target price of $119.00. The stock recently opened at $85.43, trading below its 50-day and 200-day moving averages and near its one-year low. Several research firms have adjusted their ratings, including downgrades from Zacks Research and Weiss Ratings, and a lowered price objective from Bank of America, while institutional investors like Arrowstreet have significantly increased their stakes.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-21 | Piper Sandler | $135 | $155 | -13% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-21 | Piper Sandler | main | Neutral |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.0% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 6 |

**Top Holders:**
- Vanguard Group Inc: 10.5% (+3.2%)
- Berkshire Hathaway, : 7.7% (0.0%)
- Blackrock Inc.: 6.1% (-2.0%)
- Capital World Invest: 3.8% (-43.3%)
- State Street Corpora: 3.8% (-4.2%)

### Key Risks

1. Long-term trend broken: trading 9.0% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_10 improving +2.2% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.58 elevated, pricing in significant growth expectations. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bearish (6 selling vs 3 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $25.7B |
| Beta | 0.46 |
| 52W Range | $126.45 - $240.32 |
| Short Interest | 6.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.58 |
| Forward P/E | 11.9 |
| Current P/E | 12.8 |
| YoY Growth | 8.0% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from 2.5% to 4.7% (+2.2% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (3.0-6.0%), cross-sectional ranking at 82nd percentile. MRS_5 at 2.2% confirms short-term momentum alignment. Outperforming sector by 3.4pp, stock-specific strength. Below SMA200 (0.91x), long-term trend not supportive. MACD histogram positive (1.63), confirming momentum. RSI overbought at 71, risk of mean reversion. OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 4.72% (CS: 82) | Strong |
| RSI_14 | 70.7 | Overbought |
| MACD Histogram | 1.63 | Bullish |
| vs SMA20 | 1.074x | Above |
| vs SMA50 | 1.080x | Above |
| vs SMA200 | 0.910x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $147.42
- **Stop Loss:** $141.04 (4.3% risk)
- **Target:** $156.99 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 188
- **Position Value:** $27,714.96
- **Portfolio %:** 27.71%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-01-07 (Est: $2.65)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.41 | $3.63 | +6.5% |
| 2025Q2 | $3.29 | $3.22 | -2.3% |
| 2025Q1 | $2.27 | $2.63 | +15.9% |
| 2024Q4 | $3.31 | $3.25 | -1.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*